Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : CELSION CORP. (CLN was CELN) UP $.33 TO $.59 ON HUGE NEWS -- Ignore unavailable to you. Want to Upgrade?

To: Larry Brew who wrote (223)	1/31/1999 2:00:00 PM
From: Dave Gore	Read Replies (1) \| Respond to of 518

Preclinincal on what? mice? certainly NOT human tissue The company stated.. "PRECLINICAL studies have indicated the possibility that the treatment will be non-toxic and side-effect-free." PLUS it says POSSIBILITY... so this indicates that their evidence is inconclusive and that they are still early in the process. See what I mean? If you take just ONE line out of their release, it can speak volumes about what is or is not going on? This could be good stuff lone term....I hope so....but just be careful and don't pay too much. Let's see where this stock will be later this week or next month. Then you can all say "I told ya so"